OrbiMed Asia GP IV, L.P. insider trades
OrbiMed Asia GP IV, L.P. has filed 2 Form 4s with the SEC that we hold, for ArriVent BioPharma, Inc. (AVBP) (Director, 10% owner) and KNTE (Director, 10% owner). Across all of them we count 1 purchase worth $4.0M and 0 sales worth $0 reported on Form 4. None of these purchases or sales is dated in the last 12 months. The largest single trade was a purchase of 222,222 shares of ArriVent BioPharma, Inc. worth $4.0M, dated 2024-01-30. The first filing on our record is dated 2024-01-31 and the latest 2024-04-05.
ArriVent BioPharma, Inc. (AVBP)
| Trade date | Code | Shares | Value as filed | Filed | Source |
|---|---|---|---|---|---|
| 2024-01-30 | P, purchase reported on Form 4 | 222,222 | $4.0M | 2024-01-31 | SEC |
KNTE
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1966836) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
